|
Thrombolysis
Citations 41-50 of 134 total displayed.
|
Past content
(since Feb 1998):
|
- Research Letters
Interaction of Duloxetine and Warfarin Causing Severe Elevation of International Normalized Ratio
- Charles J. Glueck; Qasim Khalil; Magdalena Winiarska; Ping Wang
JAMA 2006; 295: 1517-1518.
[Extract]
[Full text]
[PDF]
- Original Contributions
Effects of Fondaparinux on Mortality and Reinfarction in Patients With Acute ST-Segment Elevation Myocardial Infarction: The OASIS-6 Randomized Trial
- The OASIS-6 Trial Group*
JAMA 2006; 295: 1519-1530.
[Abstract]
[Full text]
[PDF]
- Editorials
Fondaparinux in ST-Segment Elevation Myocardial Infarction: The Drug, the Strategy, the Environment, or All of the Above?
- Robert M. Califf
JAMA 2006; 295: 1579-1580.
[Extract]
[Full text]
[PDF]
- Clinical Reviews
Management of Antiphospholipid Antibody Syndrome: A Systematic Review
- Wendy Lim; Mark A. Crowther; John W. Eikelboom
JAMA 2006; 295: 1050-1057.
[Abstract]
[Full text]
[PDF]
- Medical News & Perspectives
New Oral Anticoagulants Show Promise
- Tracy Hampton
JAMA 2006; 295: 743-744.
[Extract]
[Full text]
[PDF]
- Original Contributions
Excess Dosing of Antiplatelet and Antithrombin Agents in the Treatment of Non–ST-Segment Elevation Acute Coronary Syndromes
- Karen P. Alexander; Anita Y. Chen; Matthew T. Roe; L. Kristin Newby; C. Michael Gibson; Nancy M. Allen-LaPointe; Charles Pollack; W. Brian Gibler; E. Magnus Ohman; Eric D. Peterson; for the CRUSADE Investigators
JAMA 2005; 294: 3108-3116.
[Abstract]
[Full text]
[PDF]
- Original Contributions
High-Risk Patients With Acute Coronary Syndromes Treated With Low-Molecular-Weight or Unfractionated Heparin: Outcomes at 6 Months and 1 Year in the SYNERGY Trial
- Kenneth W. Mahaffey; Marc Cohen; Jyotsna Garg; Elliott Antman; Neal S. Kleiman; Shaun G. Goodman; Lisa G. Berdan; Craig J. Reist; Anatoly Langer; Harvey D. White; Philip E. Aylward; Jacques J. Col; James J. Ferguson III; Robert M. Califf; for the SYNERGY Trial Investigators
JAMA 2005; 294: 2594-2600.
[Abstract]
[Full text]
[PDF]
- Letters
Abciximab in the Treatment of ST-Segment Elevation Myocardial Infarction
- Daniel Shao-Weng Tan; David Kheng-Leng Sim; Edwin Shih-Yen Chan; Ru-San Tan
JAMA 2005; 294: 1760-a-1761-a.
[Extract]
[Full text]
[PDF]
- Letters
Abciximab in the Treatment of ST-Segment Elevation Myocardial Infarction—Reply
- Giuseppe De Luca; Harry Suryapranata
JAMA 2005; 294: 1761-a.
[Extract]
[Full text]
[PDF]
- Original Contributions
Effect of Clopidogrel Pretreatment Before Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction Treated With Fibrinolytics: The PCI-CLARITY Study
- Marc S. Sabatine; Christopher P. Cannon; C. Michael Gibson; Jose L. López-Sendón; Gilles Montalescot; Pierre Theroux; Basil S. Lewis; Sabina A. Murphy; Carolyn H. McCabe; Eugene Braunwald; for the Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY)–Thrombolysis in Myocardial Infarction (TIMI) 28 Investigators
JAMA 2005; 294: 1224-1232.
[Abstract]
[Full text]
[PDF]
|
|
